Tech Company Financing Transactions
Centauri Therapeutics Funding Round
Centauri Therapeutics, based in Kent, received $5.1 million in investment from Carb-X.
Transaction Overview
Company Name
Announced On
7/29/2025
Transaction Type
Venture Equity
Amount
$5,100,000
Round
Undisclosed
Investors
Carb-X (Erin Duffy)
Proceeds Purpose
The funds will support the advancement of the lead candidate in Centauri's ABX-01 program into first-in-human clinical studies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Discovery Park
Kent, CT13 9ND
United Kingdom
Kent, CT13 9ND
United Kingdom
Phone
Website
Email Address
Overview
Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Michael Westby
Co-Founder
Stuart Lawson
Browse more venture capital transactions:
Prev: 7/29/2025: Cafeteria venture capital transaction
Next: 7/29/2025: 4AG Robotics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC transactions on this site are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs